Eyeworld Daily News

54 | EYEWORLD DAILY NEWS | MAY 4, 2019 ONSITE by Ellen Stodola EyeWorld Senior Staff Writer/ Meetings Editor tions, will give her annual legisla- tive and regulatory affairs update today from 7:00 to 8:00 a.m. as an ASCRS instructional course and this afternoon from 4:00 to 5:00 p.m. as an ASOA course. Ms. McCann will also present "The Third Year of MIPS – What You Need to Know to be Successful," an ASOA course, on both Sunday and Monday mornings, from 10:30 to 11:30 a.m. Finally, she will pres- ent at the course "Move Toward Value-Based Payment and How it Applies to Technicians & Nurses" as part of the Technicians and Nurses program on Monday from 8:00 to 9:00 a.m. and discuss their responsibility in providing information about adverse events associated with a device, and in some cases, a volun- tary market withdrawal. Francis Mah, MD, and Douglas Rhee, MD, will discuss their work on evaluating and communicating to ASCRS membership the most recent adverse event associated with an FDA-approved device. Lastly, Leon Herndon, MD, will draw on his own experience and discuss a physician's responsibility to communicate with and mon- itor patients who have received a device associated with adverse events. The ASCRS ASOA Health Information Technology Commit- tee's session will take place today from 2:45 to 3:45 p.m. and will cover "All the EHR Tools You're Not Using: How to Optimize Cli- nician EHR Use for Better Care Coordination and Practice Work- flow." It will highlight optimizing clinician EHR use to ensure prac- tices are maximizing the potential of their EHR system. Experts will share tips to improve practice workflow using direct messaging. Speakers will also discuss new ways to engage patients in their health using a web portal. Nancey McCann, ASCRS director of Government Rela- and head of Forbes Media, will share his perspective on the move toward value-based payment and how the costs of healthcare affect the U.S. economy. Other Government Relations sessions On Sunday from 3:00 to 4:30 p.m., the ASCRS FDA Committee is sponsoring the symposium "Com- municating and Evaluating Ad- verse Events Associated with an FDA-Approved Medical Device." It will spotlight the FDA efforts to ensure the safety and effectiveness of medical technologies used in the U.S. Specifically, it will address the FDA's process for evaluating adverse events associated with an FDA-approved medical device and those that have been with- drawn from the market. Malvina Eydelman, MD, director of the Office of Ophthalmic, Anesthe- sia, Respiratory, ENT and Dental Devices, Center for Devices and Radiological Health (CDRH) at the FDA, will explain the FDA safety communications and how ophthalmologists should explain safety issues to patients who have received an FDA-approved device that is associated with adverse events. Stephen Lane, MD, and Jonathan Talamo, MD, will provide an industry perspective T his year, the Government Relations symposium will be held on a new day and time, Sunday from 1:00 to 2:30 p.m. Titled "Is This the End of Fee-for- Service?" it will explore the bipartisan effort to move phy- sicians out of Medicare fee-for- service and into advanced alterna- tive payments models (APMs). The session will feature two speakers. First, Harold Miller, MS, president and CEO of the Center for Healthcare Quality and Payment Reform, will examine the current efforts to tie physician payment to value. He will then lead a panel discussion on possible APMs in ophthalmology, including the challenges, as well as efforts to save money and improve quality, with ASCRS ophthalmologists participating in different delivery systems. Next, Steve Forbes, MA, one-time presidential candidate Government Relations sessions highlight key legislative and regulatory topics with arcuate incisions and toric IOLs, and more. Essentials on crosslinking and glaucoma will be covered in two separate symposia on Monday at 8 a.m., followed by "ASCRS TOPGUN 2019: Essential Pearls from the Best International Phaco Instructors" at 3 p.m. Reoccurring and beyond A panel of internationally recog- nized experts will take a look at the differing opinions surrounding keratoconus classification, patho- genesis, diagnosis, and treatment in "Keratoconus: Consensus and Controversy" today at 1 p.m. "Survive or Thrive in the Modern Healthcare Environment" today at 3 p.m. is back by popular demand, as is "Challenging Cases in Cataract Surgery Video Sym- posium" on Monday at 8 a.m. and "X-Rounds: Refractive Cataract Surgery to the Max" on Tuesday at 10 a.m. A symposium focused on the MIGS revolution will take place on Sunday at 8 a.m., followed by the 2019 ASCRS FDA sympo- sium, "Communicating and Eval- uating Adverse Events Associated with an FDA-approved Medical Device" later at 3 p.m. "Highlights from the Mili- tary Refractive Surgery Safety & Standards Symposium" will be presented on Monday at 8 a.m. On the same day is "EyeConnect Live: Anchorman Edition" at 1 p.m., "Managing the Unhappy Post-Re- fractive Patient" also at 1 p.m., and "The Perfect Save: Challenging Cases Managed by International Experts" at 3 p.m. There are also a couple of symposia that will be presented in Spanish: "Management of Com- plicated Cases in Cataract and Refractive Surgery" today at 3 p.m. and "Best of ASCRS" on Tuesday at 8 a.m. continued from page 52 Steve Forbes, MA Harold Miller, MS

• Blank Page
• Blank Page (1)